FU Heguan, SHEN Xuxuan, XU Jiali, ZHANG Houdi, LI Bin, ZOU Zhengxing, FENG Jie, DUAN Lian, HAN Cong. The Types and Risk Factors of Stroke in Young Patients with Moyamoya Disease[J]. Chinese Journal of Stroke, 2022, 17(09): 937-943.
[1]黄维,毕齐. 青年缺血性脑卒中病因学筛查研究现状[J]. 中国全科医学,2015,18(12):1355-1360.
[2]LI F,YANG L,YANG R,et al. Ischemic stroke in young adults of northern China:characteristics and risk factors for recurrence[J]. Eur Neurol,2017,77(3/4):115-122.
[3]SCOTT R M,SMITH E R. Moyamoya disease and moyamoya syndrome[J]. N Engl J Med,2009,360(12):1226-1237.
[4]Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis,Health Labour Sciences Research Grant for Research on Measures for Infractable Diseases. Guidelines for diagnosis and treatment of moyamoya disease(spontaneous occlusion of the circle of Willis)[J]. Neurol Med Chir(Tokyo),2012,52(5):245-266.
[5]中国高血压防治指南修订委员会,高血压联盟(中国),中华医学会心血管病学分会,等. 中国高血压防治指南(2018年修订版)[J]. 中国心血管杂志,2019,24(1):24-56.
[6]中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 国际内分泌代谢杂志,2021,41(5):482-548.
[7]中国成人血脂异常防治指南修订联合委员会. 中国成人血脂异常防治指南(2016年修订版)[J]. 中华全科医师杂志,2017,16(1):15-35.
[8]JANG D K,LEE K S,RHA H K,et al. Clinical and angiographic features and stroke types in adult moyamoya disease[J]. AJNR Am J Neuroradiol,2014,35(6):1124-1131.
[9]AHN I M,PARK D H,HANN H J,et al. Incidence,prevalence,and survival of moyamoya disease in Korea:a nationwide,population-based study[J]. Stroke,2014,45(4):1090-1095.
[10]MIAO W,ZHAO P L,ZHANG Y S,et al. Epidemiological and clinical features of moyamoya disease in Nanjing,China[J]. Clin Neurol Neurosurg,2010,112(3):199-203.
[11]DUAN L,BAO X Y,YANG W Z,et al. Moyamoya disease in China:its clinical features and outcomes[J]. Stroke,2012,43(1):56-60.
[12]SMAJLOVIĆ D,SALIHOVIĆ D,IBRAHIMAGIĆ O C,et al. Characteristics of stroke in young adults in Tuzla Canton,Bosnia and Herzegovina[J]. Coll Antropol,2013,37(2):515-519.
[13]LIU Z W,HAN C,WANG H,et al. Clinical characteristics and leptomeningeal collateral status in pediatric and adult patients with ischemic moyamoya disease[J]. CNS Neurosci Ther,2020,26(1):14-20.
[14]KIM D Y,SON J P,YEON J Y,et al. Infarct pattern and collateral status in adult moyamoya disease:a multimodal magnetic resonance imaging study[J]. Stroke,2017,48(1):111-116.
[15]O'DONNELL M J,CHIN S L,RANGARAJAN S,et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries(INTERSTROKE):a case-control study[J]. Lancet,2016,388(10046):761-775.
[16]AIGNER A,GRITTNER U,ROLFS A,et al. Contribution of established stroke risk factors to the burden of stroke in young adults[J]. Stroke,2017,48(7):1744-1751.
[17]BOWER R S,MALLORY G W,NWOJO M,et al. Diabetes mellitus and the moyamoya syndrome[J]. Ann Intern Med,2012,157(5):387-388.
[18]ZHAO M,DENG X F,GAO F L,et al. Ischemic stroke in young adults with moyamoya disease:prognostic factors for stroke recurrence and functional outcome after revascularization[J/OL]. World Neurosurg,2017,103:161-167[2022-07-15]. https://doi.org/10.1016/j.wneu.2017.03.146.
[19]MORIOKA M,HAMADA J,KAWANO T,et al. Angiographic dilatation and branch extension of the anterior choroidal and posterior communicating arteries are predictors of hemorrhage in adult moyamoya patients[J]. Stroke,2003,34(1):90-95.
[20]YANG H C,ZHANG L M,WANG M H,et al. Clinical features of and risk factors for intracranial aneurysms associated with moyamoya disease[J]. Int J Stroke,2021,16(5):542-550.
[21]KIM J S. Moyamoya disease:epidemiology,clinical features,and diagnosis[J]. J Stroke,2016,18(1):2-11.
[22]ZIAI W,CARHUAPOMA J R,NYQUIST P,et al. Medical and surgical advances in intracerebral hemorrhage and intraventricular hemorrhage[J]. Semin Neurol,2016,36(6):531-541.